Dipraglurant

Dipraglurant (INN) (code name ADX-48621) is a negative allosteric modulator of the mGlu₅ receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). As of 2014, it is in phase II clinical trials for this indication. Addex Therapeutics is also investigating an extended-release formulation of dipraglurant for the treatment of non-parkinsonian dystonia.

单词	Dipraglurant
释义	Dipraglurant 英语百科 Dipraglurant Dipraglurant (INN) (code name ADX-48621) is a negative allosteric modulator of the mGlu₅ receptor which is under development by Addex Therapeutics for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID). As of 2014, it is in phase II clinical trials for this indication. Addex Therapeutics is also investigating an extended-release formulation of dipraglurant for the treatment of non-parkinsonian dystonia.
随便看	Cytp CYTR cytrase CytRE Cytrel cytreld cytrimycin cytrin cytrinin Cytrol Cytrolane cytrs CytRx CYT. SYS. CYT SYST cyttarhagia Cyttariaceae Cyttariales cyttarrhagia cyttid cyttids cyttomimus affinis cyttopsis rosea cytula cytuloplasm